Lv31
320 积分 2022-06-09 加入
Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
2小时前
待确认
Ibrexafungerp: First Approval
3小时前
已完结
Evaluation of Antifungal Efficacy in an Optimized Animal Model ofTrichophytonmentagrophytes-Dermatophytosis
2天前
已完结
Oteseconazole: First Approval
2天前
已完结
Vulvovaginal Candidiasis-An Overview of Current Trends and the Latest Treatment Strategies
8天前
已完结
Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
9天前
已完结
[Chinese guidelines for diagnosis and treatment of vulvovaginal candidiasis (2024 edition)]
13天前
已完结
CYP51—the omnipotent P450
14天前
已完结
Changing frontline AML treatment patterns from 2013 to 2022
4个月前
已完结
Revumenib: a new era in acute leukemia treatment
7个月前
已完结
皖公网安备34019202002308
